Highlights INOVIQ Ltd

Equities

IIQ

AU0000196149

Market Closed - Australian S.E. Other stock markets 11:40:37 13/05/2024 am IST			5-day change	1st Jan Change
0.52 ^AUD	-1.89%		+5.05%	-21.80%

19/04	INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test	MT
15/04	Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test	19/04	MT
INOVIQ Signs Supply, Distribution Agreement with Promega; Shares Surge 18%	15/04	MT
Inoviq's Test Detects 19% More Breast Cancers Than Market Leader	23/02	MT
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	23/02	CI
Inoviq Signs Deal for Use of Biomarker Capture Product in the US	05/23/05	MT
INOVIQ Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30	CI
INOVIQ Limited and Promega Corporation Announce Global Joint Marketing Agreement for EXO-NET Exosome Isolation and Nucleic Acid Purification Solutions	06/23/06	CI
Inoviq Signs Global Marketing Deal for Exosome Technology	06/23/06	MT
Inoviq Limited Announces Clinical Validation Study for Subb2m/Ca15-3 Breast Cancer Test	27/23/27	CI
Inoviq Confirms Efficacy of Breast Cancer Test	27/23/27	MT
INOVIQ Limited to Present New Exo-NET Data at ISEV Annual Meeting	19/23/19	CI
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	24/23/24	CI
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	24/23/24	CI
INOVIQ Limited Announces Positive Results for SubB2M Breast Cancer Test	08/23/08	CI
INOVIQ Limited Announces the Ovarian Cancer 97 Study Completed by the Centre for Clinical Research	13/22/13	CI
Inoviq Advances Commercial Sales of Medical Products in the US; Moves Research Facility to Australia	25/22/25	MT
Inoviq Gets Canadian Patent for Lung Cancer Diagnosis Technology	27/22/27	MT
Inoviq Receives nearly $550,000 R&D Tax Refund in FY21; Shares Jump 7%	14/22/14	MT
INOVIQ Ltd Reports Earnings Results for the Full Year Ended June 30, 2022	30/22/30	CI
INOVIQ Limited Announces Positive SubB2M IHC Results for Melanoma	26/22/26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights INOVIQ Ltd

Equities

IIQ

AU0000196149

Highlights

Filters